NCT07203989

Brief Summary

This study aims to investigate the effect of video calls with family members during the preoperative waiting period in the operating room on stress, anxiety, and surgical fear in patients undergoing transurethral resection of bladder tumor (TURBT). Bladder cancer is a common urological malignancy, and psychological problems are frequently observed in the preoperative period. The absence of family support in the operating room may increase anxiety and fear, triggering physiological stress responses and raising the risk of complications. This multicenter randomized controlled trial will be conducted between September 2025 and March 2027 at Bitlis State Hospital and Tatvan State Hospital. The study sample will include 128 eligible patients, randomly assigned to intervention and control groups. Patients in the intervention group will have a video call with a designated family member in the operating room, while control group patients will receive routine care. Data will be collected using the Descriptive Information Form, the Surgical Fear Questionnaire, and the Visual Analogue Scale; stress levels will be assessed through serum cortisol and glucose values. Measurements will be taken at three time points: preoperatively (T0), immediately before anesthesia (T1), and on the first postoperative day (T2). The study is expected to demonstrate that maintaining family support through video calls in the preoperative period reduces anxiety, fear, and stress, thereby improving surgical outcomes and contributing to the development of family-centered care practices.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
124

participants targeted

Target at P50-P75 for not_applicable

Timeline
17mo left

Started Oct 2025

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress31%
Oct 2025Sep 2027

First Submitted

Initial submission to the registry

September 17, 2025

Completed
14 days until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 2, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2027

Last Updated

October 2, 2025

Status Verified

September 1, 2025

Enrollment Period

12 months

First QC Date

September 17, 2025

Last Update Submit

September 24, 2025

Conditions

Keywords

Transurethral resection of bladder tumor (TURBT)Preoperative anxietySurgical fearFamily-centered careVideo call intervention

Outcome Measures

Primary Outcomes (3)

  • Change in Anxiety Level (Visual Analogue Scale)

    Anxiety levels will be assessed using the Visual Analogue Scale (VAS), scored from 0 (no anxiety) to 10 (worst possible anxiety). Higher scores indicate greater anxiety.

    Anxiety levels will be measured at three different time points: T0: On the morning of the surgery, at 08:00 in the ward T1: In the operating room, immediately before anesthesia induction T2: The morning after the surgery, at 08:00

  • stress

    Serum cortisol and serum glucose levels will be measured to determine patients' stress levels. Increases in cortisol and glucose levels indicate increased stress levels.

    Blood samples will be collected from patients at three different times. • T0: On the morning of surgery, in the ward at 8:00 a.m. • T1: In the operating room, just before anesthesia induction • T2: The day after surgery, at 8:00 a.m.

  • Surgical Fear Level

    The Surgical Fear Scale (SFS) will be used to determine the level of fear in patients. Surgical Fear Scale: The Surgical Fear Scale was first developed by Theunissen et al. in 2014 to determine the level of surgical fear in patients undergoing surgery. The Surgical Fear Scale consists of eight items and two subscales, scored from 0 to 10. The first four items measure fear of short-term surgical outcomes, and the last four items measure fear of long-term outcomes. Each subscale is aggregated, and the sum of the two subscale scores constitutes the total scale score. The total score for the scale ranges from 0 to 80. Low scores indicate low levels of surgical fear, while high scores indicate high levels of surgical fear.

    Patients' surgical fear levels will be measured at two different times. • T0: On the morning of surgery, in the ward at 8:00 a.m. • T1: In the operating room, just before anesthesia induction

Study Arms (2)

Experimental - Intervention Group

EXPERIMENTAL

Family Meeting:Patients will have a real-time video call with one designated family member while waiting in the operating room before anesthesia induction. The call will last until anesthesia preparation begins.

Behavioral: family-supported care

Control Group

NO INTERVENTION

Standard Maintenance: Patients will undergo the standard surgical preparation and waiting process in the operating room without any contact with family members.

Interventions

Family video calling in the operating room

Also known as: Family video calling in the operating room
Experimental - Intervention Group

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older
  • Able to read and write in Turkish
  • Scheduled for transurethral resection of bladder tumor (TURBT)
  • Has a family member, friend, or relative able to participate in video calls
  • The accompanying family member or relative has a device suitable for video calls (smartphone, tablet, etc.)
  • Has waited at least 20 minutes in the operating room before surgery
  • No hearing, speech, or language-related communication barriers
  • No psychological disorders that could affect fear or anxiety
  • Not using medications that could alter fear or anxiety levels
  • Scheduled for surgery between 08:00 and 12:00
  • Willing to voluntarily participate in the study

You may not qualify if:

  • Surgery is canceled after the patient has been enrolled in the study
  • Patient chooses to withdraw from the study after enrollment
  • Individuals with any diagnosed chronic disease
  • Experiencing connection problems during the video call
  • Patients who receive premedication during the waiting period to relieve anxiety

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Tatvan State Hospital, Bitlis, Turkey

Bitlis, Tatvan, Turkey (Türkiye)

Location

Bitlis State Hospital, Bitlis, Turkey

Bitlis, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Urinary Bladder NeoplasmsNeoplasms

Condition Hierarchy (Ancestors)

Urologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrinary Bladder DiseasesUrologic DiseasesMale Urogenital Diseases

Study Officials

  • Erdoğan YAKIT

    BİTLİS EREN UNİVERSTY

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

September 17, 2025

First Posted

October 2, 2025

Study Start

October 1, 2025

Primary Completion (Estimated)

September 15, 2026

Study Completion (Estimated)

September 15, 2027

Last Updated

October 2, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

The individual participant data (IPD) will not be shared due to patient confidentiality and privacy concerns, as well as institutional regulations regarding clinical data handling.

Locations